home / stock / ebs / ebs news


EBS News and Press, Emergent Biosolutions Inc. From 05/02/24

Stock Information

Company Name: Emergent Biosolutions Inc.
Stock Symbol: EBS
Market: NYSE
Website: emergentbiosolutions.com

Menu

EBS EBS Quote EBS Short EBS News EBS Articles EBS Message Board
Get EBS Alerts

News, Short Squeeze, Breakout and More Instantly...

EBS - CytomX Therapeutics, Allarity Therapeutics, Pulmonx among healthcare movers

2024-05-02 10:00:43 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance 19 out...

EBS - Russell 2000 Q1 2024 Earnings Preview: Sharp Downward Revisions Precede Earnings Season

2024-05-02 07:10:00 ET Summary Q1 earnings growth expectations have sharply declined more than usual as we enter earnings season. Over the past three months, Q1 growth projections have been adjusted downward by 21.5 percentage points, settling at a current year-over-year decline o...

EBS - Emergent BioSolutions gains as results top estimates, co to cut 300 jobs

2024-05-02 05:22:38 ET Emergent BioSolutions' ( NYSE: EBS ) shares climbed 60% in premarket trade on Thursday, after the company surpassed Street estimates for first quarter earnings, and unveiled layoff plans.... Read the full article on Seeking Alpha For further de...

EBS - Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript

2024-05-01 23:45:15 ET Image source: The Motley Fool. Emergent BioSolutions (NYSE: EBS) Q1 2024 Earnings Call May 01, 2024 , 5:00 p.m. ET Operator Continue reading For further details see: Emergent BioSolutions (EBS) Q1 2024 Earnings Call Tran...

EBS - Emergent BioSolutions Inc. (EBS) Q1 2024 Earnings Call Transcript

2024-05-01 21:38:11 ET Emergent BioSolutions Inc. (EBS) Q1 2024 Earnings Call Transcript May 01, 2024, 05:00 PM ET Company Participants Joe Papa - President and CEO Rich Lindahl - EVP and CFO Paul Williams - SVP, Products Business Presentation Opera...

EBS - Emergent Biosolutions Non-GAAP EPS of $0.59 beats by $1.45, revenue of $300.4M beats by $75.9M

2024-05-01 17:03:46 ET More on Emergent Biosolutions Emergent BioSolutions Inc. (EBS) Q4 2023 Earnings Call Transcript Emergent BioSolutions Inc. 2023 Q4 - Results - Earnings Call Presentation New CEO Appointment A Clear Positive For Emergent BioSolutions Eme...

EBS - Emergent BioSolutions Reports First Quarter 2024 Financial Results

First Quarter 2024 Total Revenues of $300.4 million, above the prior guidance range First Quarter 2024 Net Income of $9.0 million and Adjusted EBITDA of $66.9 million Updates FY 2024 guidance GAITHERSBURG, Md., May 01, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) ...

EBS - Emergent BioSolutions announces reduction of about 300 employees

2024-05-01 16:24:49 ET More on Emergent Biosolutions New CEO Appointment A Clear Positive For Emergent BioSolutions Emergent Biosolutions Q1 2024 Earnings Preview Emergent BioSolutions receives NAI status for Baltimore Bayview manufacturing facility Read th...

EBS - Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position

Proactive changes aim to ensure long-term sustainability and growth, optimize operations, streamline processes, and allocate resources more efficiently Reorganization will align with evolving business goals, strategic priorities and new operational plan Overall efforts expected to deliver...

EBS - Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone

Nearly 9 in 10 Americans surveyed agree opioid overdoses are a concern for teenagers and college students; parents in the survey want life-saving treatment to be easily accessible in case of an emergency GAITHERSBURG, Md., May 01, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYS...

Previous 10 Next 10